In September of 2012, there will be two Congressional briefings on atrial fibrillation for National Atrial Fibrillation Awareness Month. The featured speakers on September 18 will be Hugh Calkins, MD, FHRS, a world-renowned expert on atrial fibrillation and Heart Rhythm Society (HRS) Incoming President, and Mellanie True Hills, an afib patient and CEO and Founder …
Read MoreAuthor Archives: Mellanie True Hills
The American College of Cardiology recently interviewed our founder and CEO, Mellanie True Hills, about how she came to start Atrial Fibrillation Awareness Month and what has happened as a result. Access the video at: American College of Cardiology Interviews StopAfib.org Founder About Having Created Atrial Fibrillation Awareness Month
Read MoreStopAfib.org interviews Dr. Randall Wolf of the Indiana Heart Hospital
Read MoreIn this video, creator of the mini maze surgical procedure, Dr. Randall Wolf, describes the evolution of the procedure and how it came to be called the Wolf mini maze. He also discusses the effect of a minimalist approach to lesions, as well as how the mini maze procedure compares to catheter ablation. Watch the …
Read MoreOver 10,000 patients, caregivers, healthcare professionals, policy makers and the general public from 136 countries have signed the world’s only Global Atrial Fibrillation Patient Charter calling for government action to help prevent millions of people from dying or becoming disabled by a stroke caused by Atrial Fibrillation (AF). To learn more, see: Global Support Increases …
Read MoreStopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used …
Read MoreAt Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the …
Read MoreThe Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and …
Read MoreStopAfib.org interviews Dr. Eric Prystowsky of St. Vincent's Hospital in Indianapolis, Indiana Find more on Dr. Prystowsky: www.stopafib.org Find more on rate control for the treatment of afib at: www.stopafib.org In this video, Dr. Prystowsky discussed the proper application of rate control as a method of controlling atrial fibrillation, as …
Read MoreIn this video interview recorded at Heart Rhythm 2012, Dr. Eric Prystowsky tackled the controversial topic of rate control vs. rhythm control for treating atrial fibrillation, and knowing whether you are symptomatic or asymptomatic. He also discussed the issues related to leaving afib patients on rate control long term, such as the buildup of fibrosis …
Read More